Literature DB >> 16437758

The causes and consequences of cancer-associated malnutrition.

Eric Van Cutsem1, Jann Arends.   

Abstract

Cancer-associated malnutrition can result from local effects of a tumour, the host response to the tumour and anticancer therapies. Although cancer patients often have reduced food intake (due to systemic effects of the disease, local tumour effects, psychological effects or adverse effects of treatment), alterations in nutrient metabolism and resting energy expenditure (REE) may also contribute to nutritional status. Several agents produced by the tumour directly, or systemically in response to the tumour, such as pro-inflammatory cytokines and hormones, have been implicated in the pathogenesis of malnutrition and cachexia. The consequences of malnutrition include impairment of immune functions, performance status, muscle function, and quality of life. In addition, responses to chemotherapy are decreased, chemotherapy-induced toxicity and complications are more frequent and severe, and survival times are shortened. Depression, fatigue and malaise also significantly impact on patient well-being. In addition, cancer-related malnutrition is associated with significant healthcare-related costs. Nutritional support, addressing the specific needs of this patient group, is required to help improve prognosis, and reduce the consequences of cancer-associated nutritional decline.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16437758     DOI: 10.1016/j.ejon.2005.09.007

Source DB:  PubMed          Journal:  Eur J Oncol Nurs        ISSN: 1462-3889            Impact factor:   2.398


  137 in total

1.  Changes in taste and food preferences in breast cancer patients receiving chemotherapy: a pilot study.

Authors:  Yeon-Hee Kim; Gun Min Kim; Sungtaek Son; Mina Song; Sangun Park; Hyun Cheol Chung; Seung-Min Lee
Journal:  Support Care Cancer       Date:  2019-06-22       Impact factor: 3.603

2.  Long-term follow-up of the potential benefits of early nutritional intervention in adults with upper gastrointestinal cancer: a pilot randomised trial.

Authors:  Kate Furness; Mary Anne Silvers; June Savva; Catherine E Huggins; Helen Truby; Terry Haines
Journal:  Support Care Cancer       Date:  2017-06-14       Impact factor: 3.603

3.  Assessing taste and smell alterations in cancer patients undergoing chemotherapy according to treatment.

Authors:  Javier Amézaga; Begoña Alfaro; Yolanda Ríos; Aitziber Larraioz; Gurutze Ugartemendia; Ander Urruticoechea; Itziar Tueros
Journal:  Support Care Cancer       Date:  2018-05-31       Impact factor: 3.603

Review 4.  Anorexia-Cachexia syndrome in cancer: implications of the ubiquitin-proteasome pathway.

Authors:  Carlos Camps; Vega Iranzo; Roy M Bremnes; Rafael Sirera
Journal:  Support Care Cancer       Date:  2006-07-04       Impact factor: 3.603

5.  Depression and appetite: predictors of malnutrition in gynecologic cancer.

Authors:  Ju-Hee Nho; Sung Reul Kim; Yong Soon Kwon
Journal:  Support Care Cancer       Date:  2014-07-02       Impact factor: 3.603

6.  Prevalence of hospital malnutrition in cancer patients: a sub-analysis of the PREDyCES® study.

Authors:  Mercè Planas; Julia Álvarez-Hernández; Miguel León-Sanz; Sebastián Celaya-Pérez; Krysmarú Araujo; Abelardo García de Lorenzo
Journal:  Support Care Cancer       Date:  2015-06-23       Impact factor: 3.603

7.  Prediction of clinical outcome by controlling nutritional status (CONUT) before allogeneic hematopoietic stem cell transplantation in myeloid malignancies.

Authors:  Hiroaki Araie; Yuka Kawaguchi; Motohito Okabe; Yoonha Lee; Marie Ohbiki; Masahide Osaki; Miyo Goto; Tatsunori Goto; Takanobu Morishita; Yukiyasu Ozawa; Koichi Miyamura
Journal:  Int J Hematol       Date:  2019-08-12       Impact factor: 2.490

8.  Neutrophil-to-Lymphocyte Ratio After Definitive Concurrent Chemoradiotherapy Predicts Survival in Patients With Esophageal Squamous Cell Carcinoma.

Authors:  Hyeon Kang Koh; Younghee Park; Taeryool Koo; Hae Jin Park; Me Yeon Lee; Ah Ram Chang; Semie Hong; Hoonsik Bae
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

9.  Prevalence of anxiety and depression and their risk factors in Chinese cancer patients.

Authors:  Jin Sheng Hong; Jun Tian
Journal:  Support Care Cancer       Date:  2013-10-04       Impact factor: 3.603

10.  Single dose of palonosetron plus dexamethasone to control nausea, vomiting and to warrant an adequate food intake in patients treated with highly emetogenic chemotherapy (HEC). Preliminary results.

Authors:  V Lorusso; A Spedicato; L Petrucelli; V Saracino; M Giampaglia; T Perrone
Journal:  Support Care Cancer       Date:  2009-03-18       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.